These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17081503)

  • 1. Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase.
    Gedda K; Briving C; Svensson K; Maxvall I; Andersson K
    Biochem Pharmacol; 2007 Jan; 73(2):198-205. PubMed ID: 17081503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
    Kirchhoff P; Andersson K; Socrates T; Sidani S; Kosiek O; Geibel JP
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G838-43. PubMed ID: 16798725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
    Kinoshita M; Saito N; Noto T; Tamaki H
    J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of gastric H+, K+-ATPase by 3-amino-5-methyl-2-(2-methyl-3-thienyl)imidazo[1,2-a]thieno[3,2-c]pyrid ine, SPI-447.
    Ushiro T; Tsukimi Y; Tanaka H
    Jpn J Pharmacol; 1997 Nov; 75(3):303-6. PubMed ID: 9434264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
    Zimmermann PJ; Buhr W; Brehm C; Palmer AM; Feth MP; Senn-Bilfinger J; Simon WA
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5374-8. PubMed ID: 17723299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the gastric H+,K+ -ATPase by plectrinone A, a diterpenoid isolated from Plectranthus barbatus Andrews.
    Schultz C; Bossolani MP; Torres LM; Lima-Landman MT; Lapa AJ; Souccar C
    J Ethnopharmacol; 2007 Apr; 111(1):1-7. PubMed ID: 17166678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
    Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
    Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000.
    Smolka AJ; Goldenring JR; Gupta S; Hammond CE
    BMC Gastroenterol; 2004 Feb; 4():4. PubMed ID: 15028114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of P-type ATPases by [(dihydroindenyl)oxy]acetic acid (DIOA), a K+ -Cl- cotransporter inhibitor.
    Fujii T; Ohira Y; Itomi Y; Takahashi Y; Asano S; Morii M; Takeguchi N; Sakai H
    Eur J Pharmacol; 2007 Apr; 560(2-3):123-6. PubMed ID: 17303113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The calcium-sensing receptor acts as a modulator of gastric acid secretion in freshly isolated human gastric glands.
    Dufner MM; Kirchhoff P; Remy C; Hafner P; Müller MK; Cheng SX; Tang LQ; Hebert SC; Geibel JP; Wagner CA
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1084-90. PubMed ID: 16109841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor and ion binding sites on the gastric H,K-ATPase.
    Munson K; Garcia R; Sachs G
    Biochemistry; 2005 Apr; 44(14):5267-84. PubMed ID: 15807521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
    Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y
    J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cibenzoline, an ATP-sensitive K(+) channel blocker, binds to the K(+)-binding site from the cytoplasmic side of gastric H(+),K(+)-ATPase.
    Tabuchi Y; Yashiro H; Hoshina S; Asano S; Takeguchi N
    Br J Pharmacol; 2001 Dec; 134(8):1655-62. PubMed ID: 11739241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
    Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soraprazan: setting new standards in inhibition of gastric acid secretion.
    Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide derivatives as a new class of gastric H+/K(+)-ATPase inhibitors. 1. Synthesis and structure-activity relationships of N-substituted 2-(benzhydryl- and benzylsulfinyl)nicotinamides.
    Terauchi H; Tanitame A; Tada K; Nakamura K; Seto Y; Nishikawa Y
    J Med Chem; 1997 Jan; 40(3):313-21. PubMed ID: 9022797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol e.
    Sohn SK; Chang MS; Choi WS; Kim KB; Woo TW; Lee SB; Chung YK
    Can J Physiol Pharmacol; 1999 May; 77(5):330-8. PubMed ID: 10535682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of the reversible K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity.
    Pope AJ; Boehm MK; Leach C; Ife RJ; Keeling D; Parsons ME
    Biochem Pharmacol; 1995 Nov; 50(10):1543-9. PubMed ID: 7503755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of H+/K+ ATPase in the gastroprotective effect of Baccharis illinita DC.
    Freitas CS; Baggio CH; Finau J; Anginoni M; Pizzolatti MG; Santos AR; Marques MC
    J Pharm Pharmacol; 2008 Aug; 60(8):1105-10. PubMed ID: 18644203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhibitors of Na+/H+-exchange and gastric H+/K+ ATPase on cell volume, intracellular pH and migration of human polymorphonuclear leucocytes.
    Ritter M; Schratzberger P; Rossmann H; Wöll E; Seiler K; Seidler U; Reinisch N; Kähler CM; Zwierzina H; Lang HJ; Lang F; Paulmichl M; Wiedermann CJ
    Br J Pharmacol; 1998 Jun; 124(4):627-38. PubMed ID: 9690853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.